drugset / Trial / NCT07137039
Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of adebrelimab combined with TP chemotherapy regimen as neoadjuvant therapy for locally advanced hypopharyngeal cancer
Timeline
- Start
- 2025-08-20
- Primary completion
- 2027-08-20
- Completion
- 2028-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adebrelimab | Monoclonal antibody | 1200 mg | Intravenous |
| Subject | Albumin paclitaxel | Unknown | 260 mg/m2 | Intravenous |
| Subject | Cisplatin | Other / unclassified | 60 mg/m2 | Intravenous |